Renal Transplant Patients clinical trials

Explore recruiting renal transplant patients clinical trials.

Recruiting renal transplant patients studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Renal Transplant Patients trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Blockade of the renin-angiotensin system in kidney transplant patients with the presence of renal progenitor cells in urine: randomized clinical trial.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up.

Austria, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A 3-month, phase 2, single-blind, randomised, no-treatment controlled study assessing efficacy and safety of Renaparin® for improvement of kidney graft function in deceased-donor transplant recipients, with an additional 9-month follow-up.

Austria, Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Evolution of proteinuria in renal transplant patients treated with Dapagliflozin for nephroprotection. DAPAGREFFE

France

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy and Safety Clinical Trial for Immune-Guided Prevention of CMV Infection in Low-Risk Kidney Transplantation. (INMUNOVIR Study)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation and promotion of specific adaptative immunity against polyomavirus (BKV) to prevent viral infection after kidney transplantation (BK-VAX project)

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Renal Transplant Patients trials by city

Renal Transplant Patients in Toronto Renal Transplant Patients in Vancouver Renal Transplant Patients in Montreal Renal Transplant Patients in Calgary Renal Transplant Patients in Edmonton Renal Transplant Patients in Ottawa Renal Transplant Patients in Winnipeg Renal Transplant Patients in Quebec City Renal Transplant Patients in Hamilton Renal Transplant Patients in Kitchener Renal Transplant Patients in London Renal Transplant Patients in Halifax Renal Transplant Patients in New York Renal Transplant Patients in Los Angeles Renal Transplant Patients in Chicago Renal Transplant Patients in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease